Profit Investment Management LLC maintained its stake in Parexel International Corp. (NASDAQ:PRXL) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 20,462 shares of the company’s stock at the end of the third quarter. Parexel International Corp. makes up 1.4% of Profit Investment Management LLC’s portfolio, making the stock its 24th largest position. Profit Investment Management LLC’s holdings in Parexel International Corp. were worth $1,421,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in PRXL. MSI Financial Services Inc boosted its stake in Parexel International Corp. by 17.4% in the third quarter. MSI Financial Services Inc now owns 1,690 shares of the company’s stock worth $117,000 after buying an additional 250 shares in the last quarter. Dalton Greiner Hartman Maher & Co. raised its position in shares of Parexel International Corp. by 87.6% in the third quarter. Dalton Greiner Hartman Maher & Co. now owns 447,854 shares of the company’s stock worth $31,103,000 after buying an additional 209,116 shares during the last quarter. Genesee Valley Trust Co. raised its position in shares of Parexel International Corp. by 55.8% in the third quarter. Genesee Valley Trust Co. now owns 15,043 shares of the company’s stock worth $1,045,000 after buying an additional 5,387 shares during the last quarter. Nisa Investment Advisors LLC raised its position in shares of Parexel International Corp. by 2.0% in the third quarter. Nisa Investment Advisors LLC now owns 31,300 shares of the company’s stock worth $2,174,000 after buying an additional 600 shares during the last quarter. Finally, Fox Run Management L.L.C. bought a new position in shares of Parexel International Corp. during the third quarter worth $306,000. Institutional investors and hedge funds own 96.00% of the company’s stock.

Institutional Ownership by Quarter for Parexel International Corp. (NASDAQ:PRXL)

Shares of Parexel International Corp. (NASDAQ:PRXL) traded down 0.32% during midday trading on Monday, reaching $58.34. The firm’s 50 day moving average price is $61.28 and its 200 day moving average price is $64.21. The company has a market capitalization of $3.11 billion, a price-to-earnings ratio of 18.69 and a beta of 0.91. Parexel International Corp. has a 12 month low of $51.16 and a 12 month high of $71.13.

Parexel International Corp. (NASDAQ:PRXL) last posted its quarterly earnings results on Wednesday, October 26th. The company reported $0.76 earnings per share for the quarter, missing the consensus estimate of $0.86 by $0.10. Parexel International Corp. had a net margin of 7.09% and a return on equity of 30.71%. The company earned $500.90 million during the quarter, compared to the consensus estimate of $525.15 million. During the same period last year, the firm posted $0.70 earnings per share. The company’s revenue for the quarter was down 2.2% on a year-over-year basis. Equities research analysts expect that Parexel International Corp. will post $3.75 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “Profit Investment Management LLC Has $1,421,000 Position in Parexel International Corp. (PRXL)” was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece on another site, it was stolen and republished in violation of international trademark and copyright law. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2016/11/29/profit-investment-management-llc-has-1421000-position-in-parexel-international-corp-prxl.html.

PRXL has been the subject of a number of research analyst reports. Jefferies Group upped their target price on shares of Parexel International Corp. from $70.00 to $72.50 and gave the stock a “hold” rating in a research note on Friday, August 5th. Wells Fargo & Co. lowered shares of Parexel International Corp. from an “outperform” rating to a “market perform” rating in a research note on Wednesday, November 23rd. Robert W. Baird lowered shares of Parexel International Corp. from an “outperform” rating to a “neutral” rating and reduced their target price for the stock from $78.00 to $67.00 in a research note on Thursday, October 27th. Citigroup Inc. upped their target price on shares of Parexel International Corp. from $74.00 to $80.00 and gave the stock a “buy” rating in a research note on Friday, August 5th. Finally, SunTrust Banks Inc. lowered shares of Parexel International Corp. from a “buy” rating to a “hold” rating and reduced their target price for the stock from $80.00 to $60.00 in a research note on Friday, November 11th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and three have given a buy rating to the company’s stock. Parexel International Corp. currently has a consensus rating of “Hold” and an average price target of $66.70.

Parexel International Corp. Company Profile

PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company, which provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology products and services to the pharmaceutical, biotechnology and medical device industries across the world.

5 Day Chart for NASDAQ:PRXL

Receive News & Stock Ratings for Parexel International Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Parexel International Corp. and related stocks with our FREE daily email newsletter.